This is the supplier profile page of BO WOO TRADING CO, where buyers can explore products, connect directly with the supplier for pricing inquiries.
1.1
1135 WON JI LI JU
1 inquiries
Add Favorite
Report Supplier
Business Description
By Building an Open-access Platform with the Most Comprehensive Capabilities and Technologies in the Global Healthcare Industry
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, advanced therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received an AA ESG rating from MSCI for the fourth consecutive year in 2024 and its open-access platform is enabling more than 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and
Supporting our customers to deliver groundbreaking treatments to patients around the world
Collaborating with partners to deliver comprehensive capabilities and innovative technologies in the pharmaceutical and healthcare industry
WuXi AppTec Receives Gold Medal in 2024 EcoVadis Sustainability Rating
WuXi AppTec's Couvet Site Receives EcoVadis 2024 Silver Medal Rating
WuXi AppTec Ranked #1 in Global Life Sciences Tools & Services Industry in 2024 S&P Global Corporate Sustainability Assessment
WuXi AppTec Named Global CRDMO Company of the Year by Frost & Sullivan for the Eighth Consecutive Year
Despite External Challenges, WuXi AppTec Revenue and Profit Continued to Grow QoQ in the First Three Quarters of 2024; the Third Quarter Revenue Back to RMB 10+ Billion, Up 14.6% YoY Excluding COVID-19 Commercial Projects; Backlog Up 35.2% YoY
WuXi AppTec Maintains AA MSCI ESG Rating for the Fourth Consecutive Year
Shanghai, November 20, 2024 - WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, announced that it has been awarded a gold medal in the 2024 EcoVadis business sustainability rating, ranking in the top 2% of all participating companies. This achievement reflects WuXi AppTec’s commitment to sustainability and its ongoing efforts to integrate environmental and social responsibilities into the company’s business strategies and operations.
Couvet, Switzerland - November 14, 2024 - WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, is proud to announce that its facility in Couvet, Switzerland, has received a silver medal in the 2024 business sustainability ratings by EcoVadis, a leading business sustainability rating provider. This recognition highlights WuXi AppTec’s steadfast commitment to integrating Environmental, Social, and Governance (ESG) priorities into its strategy and operations.
Business Overview
Avg Response Time
≤ 1h
Total inquiries received
1
Trade Capabilities
Business Terms
Trade Ability
